Drug General Information
Drug ID	D08UML
Former ID	DNC013732
Drug Name	1-(Butan-2-ylidene)thiosemicarbazide
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529513]
Structure		Download 2D MOL 3D MOL
Formula	C5H11N3S
Canonical SMILES	CCC(=NNC(=S)N)C
InChI	1S/C5H11N3S/c1-3-4(2)7-8-5(6)9/h3H2,1-2H3,(H3,6,8,9)/b7-4-
InChIKey	NCQXVINEPVAIDB-DAXSKMNVSA-N
PubChem Compound ID	5363036
Target and Pathway
Target(s)	Tyrosine oxidase	Target Info	Inhibitor	[529513]
BioCyc Pathway	(S)-reticuline biosynthesis
	Eumelanin biosynthesis
	L-dopachrome biosynthesis
KEGG Pathway	Tyrosine metabolism
	Riboflavin metabolism
	Metabolic pathways
	Melanogenesis
PathWhiz Pathway	Riboflavin Metabolism
	Tyrosine Metabolism
WikiPathways	Dopamine metabolism
References
Ref 529513	Eur J Med Chem. 2009 Apr;44(4):1773-8. Epub 2008 Apr 27.A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds.
Ref 529513	Eur J Med Chem. 2009 Apr;44(4):1773-8. Epub 2008 Apr 27.A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.